Deciphering the implications of MAFLD and MASLD definitions in the NAFLD population:results from a single-center biopsy study

作     者：Eda Kaya Yusuf Yilmaz 

作者机构：Department of Internal MedicineRuhr University BochumUniversity Hospital Knappschaftskrankenhaus BochumBochum 44892Germany Institute of GastroenterologyMarmara Universityİstanbul 34840Turkey Department of GastroenterologySchool of MedicineRecep Tayyip Erdoğan UniversityRize 53100Turkey 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2024年第137卷第5期

页      面：616-618页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：NAFLD liver MAF 

摘      要：To the Editor:The nomenclature for steatotic liver disease has been a topic of debate since *** conventional expression,non-alcoholic fatty liver disease(NAFLD),was introduced in 1980 to describe the occurrence of steatosis in the absence of other hepatic ***,in recent years,there has been a growing movement to phase out and retire this *** 2020,Eslam et al^([1])proposed a new definition—metabolic(dysfunction)associated fatty liver disease(MAFLD)—redefining the disease to include hepatic steatosis along with other factors such as diabetes,obesity,overweight,or meeting the criteria for metabolic dysfunction.